NASDAQ
Ekso Bionics Holdings, Inc. (EKSO) has a price/sales ratio of 1.64x as of Friday, May 22, 2026. This represents a 1.50% decrease compared to its 12-month average of 1.66x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.